擅長(zhǎng): 1.營(yíng)養(yǎng)因素與慢性疾病(骨質(zhì)疏松、心腦血管疾病、糖尿病、肥胖等)。2.慢性疾病的危險(xiǎn)因素及防制措施研究。
簡(jiǎn)介: 教育經(jīng)歷2004.1-2005.1 博士后研究員,香港中文大學(xué)社區(qū)及家庭醫(yī)學(xué)系,營(yíng)養(yǎng)流行病學(xué)方向。1999.1-2003.7 博士研究生/副研究員. 香港中文大學(xué)社區(qū)及家庭醫(yī)學(xué)系,營(yíng)養(yǎng)流行病學(xué)方向。1988.9-1991.7 碩士研究生,同濟(jì)醫(yī)科大學(xué)營(yíng)養(yǎng)與食品衛(wèi)生系。1983.9-1988.7 本科生, 湖南醫(yī)科大學(xué)預(yù)防醫(yī)學(xué)系。工作經(jīng)歷2008.12-至今. 教授,中山大學(xué)公共衛(wèi)生學(xué)院醫(yī)學(xué)統(tǒng)計(jì)與流行病學(xué)系。2009.1-至今 Adjunct Associate Professor, School of Public Health &Primary Care, The Chinese University of Hong Kong。2004.4-2008.12 副教授,中山大學(xué)公共衛(wèi)生學(xué)院醫(yī)學(xué)統(tǒng)計(jì)與流行病學(xué)系。2003.7-2004.4 講師,中山大學(xué)醫(yī)學(xué)統(tǒng)計(jì)與流行病學(xué)系。1994.10-2003.7 講師,中山(醫(yī)科)大學(xué)營(yíng)養(yǎng)系/營(yíng)養(yǎng)與食品衛(wèi)生學(xué)教研室。1991.7-1994.9 助教, 中山醫(yī)科大學(xué)營(yíng)養(yǎng)與食品衛(wèi)生學(xué)教研室。社會(huì)兼職1.廣東省營(yíng)養(yǎng)學(xué)會(huì)第四屆理事會(huì)常務(wù)理事/秘書(shū)長(zhǎng)。2.廣東省慢性病流行病學(xué)分會(huì)委員會(huì)常務(wù)委員。3.廣東省預(yù)防醫(yī)學(xué)會(huì)流行病學(xué)分會(huì)委員會(huì)委員。4.廣州市預(yù)防醫(yī)學(xué)會(huì)委員會(huì)委員[1] 。研究方向編輯1.營(yíng)養(yǎng)因素與慢性疾?。ü琴|(zhì)疏松、心腦血管疾病、糖尿病、肥胖等)。2.慢性疾病的危險(xiǎn)因素及防制措施研究。主要承擔(dān)與參加的課題:青少年、哺乳期婦女、絕經(jīng)期婦女鈣需要量研究。國(guó)家十一五支撐項(xiàng)目“我國(guó)重點(diǎn)人群鐵、鈣需要和膳食應(yīng)用研究(2008BAI58B02)”分題。批準(zhǔn)年月:2008.11,起止年月,2009.1-2010.12。Co-PI。候選基因及膳食模式對(duì)婦女髖骨骨折的交互作用。國(guó)家自然科學(xué)基金,批準(zhǔn)年月:2008.9,批準(zhǔn)號(hào):30872100,主持人。飲食與肥胖相關(guān)基因?qū)Ψ逝稚賰禾谴x的影響.2006年度教育部“新世紀(jì)優(yōu)秀人才支持計(jì)劃”主持人編號(hào):NCET-06-0719。常見(jiàn)慢病的患病與發(fā)病趨勢(shì)及其影響因素的前瞻性研究。中山大學(xué)“臨床醫(yī)學(xué)研究5010計(jì)劃”。編號(hào)2007032;2007.11-2015.10。.乳母鈣需要量研究。教育部。2005.1-2006.12,主持人。青少年肥胖與糖尿病防治的干預(yù)研究。廣州市科技局。2005.10-2007.12,總題第二,分題“廣州市學(xué)齡兒童青少年肥胖現(xiàn)患率及其影響因素的調(diào)查”主持人。更年期婦女的雙穩(wěn)定同位素標(biāo)記的鈣平衡試驗(yàn)研究(2000-2002)第一完成人。大豆異黃酮對(duì)更年期婦女骨質(zhì)流失及心血管危險(xiǎn)因素的影響:雙盲、安慰劑隨機(jī)對(duì)照臨床試驗(yàn)研究.(2000-2002)第一完成人。.植物雌激素對(duì)停經(jīng)婦女鈣代謝的影響.(2001-2003,香港政府研究基金委課題,120萬(wàn)),第一完成人。青春期女童鈣需要量研究——雙穩(wěn)定同位素標(biāo)記的鈣平衡試驗(yàn)法.2003-2006,中國(guó)營(yíng)養(yǎng)學(xué)會(huì).主持人。發(fā)表的論文(僅列第一作者和通信作者):1. Dai XW, Zhang B, Wang P, ChenCG, Chen YM* (陳裕明,下同), Su YX. Erythrocyte membrane n-3 fatty acid levels and carotidatherosclerosis in Chinese. Atherosclerosis232 (2014) 79-85. (IF 3.7)2. Zeng FF, Wu BH, Fan F, Xie HL,Xue WQ, Zhu HL, Chen YM*. Dietarypatterns and the risk of hip fractures in elderly Chinese: a matchedcase-control study.J Clin Endocrinol Metab. 2013 Jun;98(6):2347-55.doi: 10.1210. (IF 6.43)3. Zeng FF, Xu CH, Liu YT, Fan YY,Lin XL, Lu YK, Zhang CX, ChenYM*.Choline and betaine intakes are associatedwith reduced risk of nasopharyngeal carcinoma in adults: a case-control study. Br JCancer. 2013 Oct 29. doi: 10.1038/bjc.2013.686. (IF 5.08)4. Liu YT, Fan YY, Xu CH, Lin XL,Lu YK, Zhang XL, Zhang CX, ChenYM*. Habitual consumption of soy products and risk ofnasopharyngeal carcinoma in chinese adults: a case-control study.PLoS One. 2013 Oct 14;8(10):e77822. doi: 10.1371. (IF 3.73)5. Liu J, Zeng FF, Liu ZM, ZhangCX, Ling WH, Chen YM*. Effectsof blood triglycerides on cardiovascular and all-cause mortality:a systematic review and meta-analysis of 61 prospective studies.Lipids Health Dis. 2013 Oct 29;12(1):159. (IF 2.04)6. Zhang ZQ, Liu YH, Xu Y, Dai XW,Ling WH, Su YX, Chen YM*. Thevalidity of the Body Adiposity Index in predicting percentage body fat andcardiovascular risk factors among Chinese.Clin Endocrinol (Oxf). 2013 Oct 17. doi: 10.1111/cen.12351. (IF 3.39)7. Zhang ZQ, Deng J, He LP, LingWH, Su YX, Chen YM*. Comparisonof various anthropometric and body fat indices in identifying cardiometabolicdisturbances in Chinese men and women.PLoS One. 2013Aug 12;8(8):e70893. doi: 10.1371. (IF 3.73)8. Xie HL, Ouyang WF, Wu BH, TuSL, Xue WQ, Fan F, Chen YM*.A case-control study regarding tea consumption and risk of hip fracturesin middle-aged and elderly Chinese.Zhonghua Liu Xing Bing Xue Za Zhi. 20139. Zeng FF, Fan F, Xue WQ, Xie HL,Wu BH, Tu SL, Ouyang WF, ChenYM*. The association of red meat, poultry, and egg consumptionwith risk of hip fractures in elderly Chinese: a case-control study.BONE. 2013Oct;56(2):242-8. doi: 10.1016. (IF 3.8)10. Zhang ZQ, Ho SC, Chen ZQ, Zhang CX, Chen YM*. Referencevalues of bone mineral density and prevalence of osteoporosis in Chineseadults.OsteoporosInt. 2013 Jun 26. (IF 4.04)11. Liu YH, Xu Y, Wen YB, Guan K, Ling WH, He LP, Su YX, Chen YM*. Associationof weight-adjusted body fat and fat distribution with bone mineral density inmiddle-aged chinese adults: a cross-sectional study.PLoS One. 2013May 20;8(5):e63339. doi: 10.1371. (IF 3.73)12. Xie HL, Wu BH, Xue WQ, HeMG, Fan F, Ouyang WF, Tu SL, Zhu HL, ChenYM*. Greater intake of fruit and vegetables is associated with alower risk of osteoporotic hip fractures in elderly Chinese: a 1:1 matchedcase-control study.Osteoporos Int. 2013 May 15. (IF 4.04)13. Fan F, Xue WQ, Wu BH, He MG, Xie HL, Ouyang WF, Tu SL, Chen YM*. Higherfish intake is associated with a lower risk of hip fractures in Chinese men andwomen: a matched case-control study.PLoS One.2013;8(2):e56849. doi: 10.1371. (IF 3.73)14. Wang P, Chen YM*,He LP, Chen CG, Zhang B, Xue WQ, Su YX. Association ofnatural intake of dietary plant sterols with carotid intima-media thickness andblood lipids in Chinese adults: a cross-section study.PLoS One.2012;7(3):e32736. doi: 10.1371. (IF 3.73)15. Li JJ, Huang ZW, Wang RQ, Ma XM, Zhang ZQ, Liu Z, Chen YM*, Su YX. Fruit andvegetable intake and bone mass in Chinese adolescents, young and postmenopausalwomen.PublicHealth Nutr. 2013 Jan;16(1):78-86. (IF2.25)16. Liu YT, Dai JJ, Xu CH, Lu YK, Fan YY, Zhang XL, Zhang CX, Chen YM*. Greaterintake of fruit and vegetables is associated with lower risk of nasopharyngealcarcinoma in Chinese adults: a case-control study.Cancer Causes Control. 2012 Apr;23(4):589-99. (IF 3.2)17. Ye YB, Wang ZL, Zhuo SY, Lu W, Liao HF, Verbruggen M, Fang S, Mai HY, Chen YM*, Su YX. Soy germisoflavones improve menopausal symptoms but have no effect on blood lipids inearly postmenopausal Chinese women: a randomized placebo-controlled trial.Menopause. 2012 Jul;19(7):791-8. doi: 10.1097/gme.0b013e31823dbeda. (IF 3.16)18. Xue WQ, Deng J, Li JJ, Liu J, He LP, Chen ZQ, Chen YM*. Associationbetween risk factors of cardiovascular diseases and osteoporosis inpostmenopausal Chinese women.Zhonghua Liu Xing Bing Xue Za Zhi. 2011Jun;32(6):554-8. Chinese.19. Zhang B, Wang P, Chen CG, He QQ, Zhuo SY, Chen YM*, Su YX. Validationof an FFQ to estimate the intake of fatty acids using erythrocyte membranefatty acids and multiple 3d dietary records.Public Health Nutr. 2010Oct;13(10):1546-52. (IF2.25)20. Chen YM, Ho SC*, Lam SS, Ho SS, Woo JL. Soyisoflavones have a favorable effect on bone loss in Chinese postmenopausalwomen with lower bone mass: a double-blind, randomized, controlled trial.Journal of Clinical Endocrinology & Metabolism. 2003 Oct; 88(10):4740-4747.(IF 6.3) (Times Cited: 73)21. Ho SC*, Chen YM, Woo JLF.Educational level and osteoporosis risk in postmenopausal Chinese women. AmericanJournal of Epidemiology 2005;161(7):680-90. (IF 5.3) (Times Cited: 10)22. Ho SC*, Chen YM, Woo JLF, Lam SS.High habitual calcium intake attenuates bone loss in early postmenopausalChinese women: an 18-month follow-up study. Journal of Clinical Endocrinology& Metabolism 2004; 89(5):2166-70. (IF 6.3) (Times Cited: 11)23. Chen YM, Ho SC*,Lam SS. Higher sea fish intake is associated greater bonemass and lower osteoporosis risk in postmenopausal Chinese women. OsteoporosisInternational. 2009 Aug 6. [Epub ahead of print] (F4.3)24. Li X, He GP, Zhang B, Chen YM*, Su YX*. Interactions of interleukin-6gene polymorphisms with calcium intake and physical activity on bone mass inChinese pre-menarche girls. Osteoporosis International 2008 Nov;19(11):1629-37. (IF4.3)25. Wang CL, Tang XY, Chen WQ, SuYX, Zhang CX, Chen YM*. Associationof Estrogen Receptor a Gene Polymorphisms with Bone Mineral Density in Chinese Women: AMeta-Analysis. Osteoporosis International 2007;18(3):295-305 (IF 4.3) (TimesCited: 6)26. Liu J, Ho SC, Su YX, Chen WQ, ZhangCX, Chen YM *. Effect of long-termintervention of soy isoflavones on bone mineral density in women: Ameta-analysis of randomized controlled trials. Bone 2009 May;44(5):948-53. (IF4.1) (Times Cited: 4)27. Chen YM, Ho SC*. Lam SSH, Ho SSS, Woo JLF. Beneficial effect of soy isoflavones onbone mineral content was modified by years since menopause, body weight, andcalcium intake: a double-blind, randomized, controlled trial. Menopause 2004;11(3): 246-254. (IF 3.7) (Times Cited: 24)28. Chen YM, Teucher B, Tang XY, Dainty JR, Lee KK,Woo JL, Ho SC*. Calcium Absorption in PostmenopausalChinese Women: A Randomized Crossover Intervention Study. British Journal ofNutrition 2007;97(1):160-6. (IF 2.8) (Times Cited: 2)29. Chen YM, Ho SC*, Woo JLF. Greater fruit andvegetable intake is associated with increased bone mass among postmenopausalChinese women. British Journal of Nutrition 2006; 96(4):745-51 (IF 2.8) (Times Cited: 11)30. Liu Z, Qiu L, Chen YM *, Su YX *. Effect of milk andcalcium supplementation on bone density and bone turnover in pregnant Chinesewomen: a randomized controlled trai. Arch Gynecol Obstet. 2010 Jan 1.31. Ho SC*,Chen YM, Woo JL, Leung SS,Lam TH, Janus ED. Sodium is the leading dietary factor associated with urinarycalcium excretion in Hong Kong Chinese adults. Osteoporosis International.2001; 12(9):723-31. (IF 4.3) (Times Cited: 9) (IF 4.3)32. Chen YM and Suzanne C. Ho. Fruit, Vegetables, andBone Health. In Ronald Ross Watson and Victor R. Preedy, editors: BioactiveFoods in Promoting Health, Oxford Academic Press, 2009; pp. 173-194. (Book Chapter)33. He LP, Tang XY, Ling WH, ChenWQ, Chen YM *. Early C-reactiveprotein in the prediction of long-term outcomes after acute coronary syndromes:a meta-analysis of longitudinal studies. Heart. 2010;96(5):339-346. (IF 5.0)34. Zhang B, Chen YM*, Huang LL, Zhou XX, Chen CG, Ye YB, Su YX*. Greaterhabitual soyfood consumption is associated with decreased carotid intima-mediathickness and better plasma lipids in Chinese middle-aged adults.Atherosclerosis 2008 June; 198(2): 403-411. (IF 4.6) (Timecited:3)35. Chen YM, Ho SC*, Lam SS, Chan SS. Validity of bodymass index and waist circumference in the classification of obesity as comparedto percent body fat in Chinese middle-aged women. International Journal of Obesity 2006; 30(6): 918-925. (IF 3.6) (TimesCited: 11)36. Wu JN, Ho SC, Zhou C, Ling WH,Chen WQ, Wang CL, Chen YM *. Coffeeconsumption and risk of coronary heart diseases: A meta-analysis of 21prospective cohort studies. Int J Cardiol. 2009; 137(3): 216-225 (IF3.1)37. Guo KP, Zhang B, Chen CG, Uchiyama S, Ueno T, Chen YM*, Su YX*. Daidzein-metabolizingphenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China. BritishJournal of Nutrition. 2010, Jan; accepted (IF 2.8)38. Ho SC*, Chen YM, Woo JL, Leung SS,Lam TH, Janus ED. Association between simple anthropometric indices andcardiovascular risk factors. International Journal of Obesity. 2001 Nov;25(11):1689-97. (IF 3.6) (Times Cited: 70)39. Ho SC*,Chen YM, Ho SS, Woo JL. Soy isoflavone supplementation and fasting serum glucose and lipidprofile among postmenopausal Chinese women: A double-blind, randomized,placebo-controlled trial. Menopause. 2007; 14(5): 905-912. (IF 3.5)40 . Chen L, Chen YM, Wang LJ,Wei J, Tan YZ, Zhou JY, Yang Y, Chen YM, Ling WH, Zhu HL.Higher homocysteine and lower betaine increase the risk ofmicroangiopathy in patients with diabetes mellitus carrying the GG genotype ofPEMT G774C. Diabetes Metab Res Rev. 2013Nov;29(8):607-17. doi: 10.1002/dmrr.2432. (共同第一)41. 鄧娟, 曾壁強(qiáng),陳裕明*,蘇宜香. 蔬菜、水果及大豆食物對(duì)高血脂病人血脂的影響. 營(yíng)養(yǎng)學(xué)報(bào). 2009; 31(5): 447-50, 45542 劉 靜,蘇宜香,鄧 娟,吳江南,陳裕明*. 大豆異黃酮干預(yù)對(duì)婦女骨密度影響的meta分析. 營(yíng)養(yǎng)學(xué)報(bào). 2008; 30(5):502-7 (10月)43. 熊莉華,王翠玲,陳宗遒,翁建平,陳維清,麥錦城,陳裕明*. 飲食偏好及行為對(duì)中小學(xué)生超重或肥胖影響的病例對(duì)照研究. 中華流行病學(xué)雜志 2008; 29(6): 561-544. 陳裕明*,何麗萍,麥錦城,郝元濤,熊莉華,陳維清,吳江南. 兒童青少年生存質(zhì)量普適性核心量表信度效度評(píng)價(jià). 中華流行病學(xué)雜志 2008;29(6): 561-5.45. 吳江南,陳裕明*,王翠玲. 丙型、乙型肝炎病毒感染對(duì)原發(fā)性肝癌影響的薈萃分析. 中華肝臟病雜志 2007; 15(2):137-140.46. 唐新意,肖作源,李詠梅,朱順葉,牟一坤, 陳裕明*. 小于胎齡兒產(chǎn)科危險(xiǎn)因素的病例對(duì)照研究. 中華流行病學(xué)雜志 2005;26(11):56-9.47. 陳裕明, 朱惠蓮, 王身笏等. 多酚對(duì)大鼠血脂及機(jī)體脂質(zhì)過(guò)氧化作用的影響. 中國(guó)老年學(xué)雜志1998.04.20; 18(2): 100-102.48. 陳裕明, 朱惠蓮, 王身笏等. 魚(yú)翅海參營(yíng)養(yǎng)液抗衰老和降血脂作用的實(shí)驗(yàn)研究. 中國(guó)老年學(xué)雜志1996.06.20; 16(3): 178-180.49. 陳裕明, 周韞珍. 不同食用油對(duì)大鼠機(jī)體脂類(lèi)與過(guò)氧化酯類(lèi)含量的影響. 營(yíng)養(yǎng)學(xué)報(bào) 1993; (3): 293-298.50. 周韞珍 陳裕明。棕櫚油對(duì)血脂和脂質(zhì)過(guò)氧化作用的影響. 營(yíng)養(yǎng)學(xué)報(bào) 1994.03.03; 16(1): 13-17.參編教材與論著:HoSCand,ChenYM.Nutrition and bone health in the Asian population. New SA and Bon jourJP.(Eds)NutritionalAspectsofBoneHealth.TheRoyalSocietyofChemistry,CamertonUK:2003;pp497-526。陳裕明健康相關(guān)生存質(zhì)量.黃民主主編.臨床流行病學(xué),高等教育出版社2008。陳裕明流行病學(xué)研究中的偏倚與控制.王建華主編.流行病學(xué),人民衛(wèi)生出版社2008。
第一執(zhí)業(yè)
糖尿病、慢性腎病、肥胖等代謝性疾病營(yíng)養(yǎng)治療、兒童、孕產(chǎn)婦營(yíng)養(yǎng)咨詢(xún)、手術(shù)前后營(yíng)養(yǎng)支持、中風(fēng)后及腫瘤家庭腸內(nèi)腸外營(yíng)養(yǎng)、營(yíng)養(yǎng)不良治療。
辨證用膳
1、糖尿病、血脂異常、脂肪肝、痛風(fēng)、慢性腎?。–KD)、營(yíng)養(yǎng)不良等疾病的醫(yī)學(xué)營(yíng)養(yǎng)治療;2、減肥、增重和胃腸功能調(diào)理;3、孕期和兒童營(yíng)養(yǎng);4、腸外、腸內(nèi)營(yíng)養(yǎng)支持和營(yíng)養(yǎng)補(bǔ)充劑的合理應(yīng)用。
北京衛(wèi)人中醫(yī)醫(yī)院
北京中科血康血液病醫(yī)學(xué)研究院
北京國(guó)醫(yī)西直門(mén)醫(yī)院
北京軍海癲癇病醫(yī)院
北京整形美容醫(yī)院
北京首大眼耳鼻喉醫(yī)院
北京豐臺(tái)英博中西醫(yī)結(jié)合醫(yī)院
中國(guó)疾病預(yù)防控制中心
北京口腔醫(yī)院
北京龍城醫(yī)院
北京維恩口腔醫(yī)院
北京西爾口腔醫(yī)院
北京中諾口腔醫(yī)院
北京凱潤(rùn)婷醫(yī)療整形美容醫(yī)院
北京京城皮膚醫(yī)院牛皮癬
北京婦科醫(yī)院
北京胎記醫(yī)院
復(fù)旦大學(xué)附屬口腔醫(yī)院
上海市楊浦區(qū)中醫(yī)醫(yī)院
上海市浦東新區(qū)中醫(yī)醫(yī)院
上海市第一康復(fù)醫(yī)院
上海市楊浦區(qū)婦幼保健院
上海市東方乳腺疾病醫(yī)院
上海市浦東新區(qū)精神衛(wèi)生中心
上海新視界眼科醫(yī)院
上海腫瘤醫(yī)院
上海市寶山區(qū)精神衛(wèi)生中心
上海市閔行區(qū)婦幼保健院
上海市黃浦區(qū)精神衛(wèi)生中心
上海市徐匯區(qū)牙病防治所
廣東羅浮山國(guó)藥股份有限公司是一家從事藥品生產(chǎn),藥品經(jīng)營(yíng),中草藥收購(gòu)等業(yè)務(wù)的公司,成立于2008年12月24日,公司坐落在廣東省,詳細(xì)地址為:惠州市博羅縣長(zhǎng)寧鎮(zhèn)廣汕公路邊嶺排工業(yè)區(qū)(羅浮山藥業(yè)城);經(jīng)國(guó)
北京韓美藥品有限公司(以下簡(jiǎn)稱(chēng)北京韓美)成立于1996年3月,公司產(chǎn)品業(yè)務(wù)涉及兒科產(chǎn)品、消化科產(chǎn)品、骨科產(chǎn)品、抗感染藥等領(lǐng)域,98%的產(chǎn)品在國(guó)內(nèi)成產(chǎn),主要產(chǎn)品有媽咪愛(ài)、易坦靜、易安平、美常安、利動(dòng)、
益普生集團(tuán)作為一家有著八十多年制藥經(jīng)驗(yàn)的歐洲制藥集團(tuán),擁有20余種上市產(chǎn)品及遍布全球近4000名的員工。公司的發(fā)展戰(zhàn)略是以三大治療領(lǐng)域內(nèi)的高科技產(chǎn)品為基礎(chǔ),即腫瘤、內(nèi)分泌、神經(jīng)肌肉類(lèi)疾病,這些高
北京同仁堂股份有限公司同仁堂制藥廠成立于1990年11月21日,注冊(cè)地位于北京市大興區(qū)中關(guān)村科技園區(qū)大興生物醫(yī)藥產(chǎn)業(yè)基地天貴大街33號(hào),法定代表人為張朝華。經(jīng)營(yíng)范圍包括加工、制造中成藥;出租辦公用房
輝瑞在中國(guó)業(yè)務(wù)覆蓋全國(guó)300余個(gè)城市,并在華上市了五大領(lǐng)域的高品質(zhì)的創(chuàng)新藥物,包括腫瘤、疫苗、抗感染、炎癥與免疫、罕見(jiàn)病等多個(gè)領(lǐng)域的處方藥和疫苗。多年來(lái),輝瑞始終致力于“成為中國(guó)醫(yī)療衛(wèi)生體系重要組成
石家莊以嶺藥業(yè)股份有限公司于1992年6月16日創(chuàng)建,公司以“繼承創(chuàng)新、造福人類(lèi)”為企業(yè)宗旨,以“科技健康明天”為企業(yè)發(fā)展目標(biāo),以健康人類(lèi)為己任,造福社會(huì)為弘愿,始終堅(jiān)持市場(chǎng)龍頭、科技驅(qū)動(dòng)的創(chuàng)新發(fā)展
北京同仁堂科技發(fā)展股份有限公司制藥廠成立于1980年07月31日,注冊(cè)地位于北京市豐臺(tái)區(qū)南三環(huán)中路20號(hào),法定代表人為王煜煒。經(jīng)營(yíng)范圍包括制造膠劑、口服液、丸劑、顆粒劑、糖漿劑、擦劑、氣霧劑、軟膠囊
海南碧凱藥業(yè)有限公司成立于1993年。是【國(guó)家高新技術(shù)企業(yè)】、國(guó)家工商總局【守合同重信譽(yù)單位】、??诠I(yè)【十佳企業(yè)】。擁有各類(lèi)人才,員工近2000人。生產(chǎn)基地位于??谒幑?,占地134畝,建筑面積10